19-52349219-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001161425.2(ZNF610):c.47G>A(p.Gly16Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000093 in 1,613,014 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001161425.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF610 | NM_001161425.2 | c.47G>A | p.Gly16Glu | missense_variant | 3/6 | ENST00000403906.8 | NP_001154897.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF610 | ENST00000403906.8 | c.47G>A | p.Gly16Glu | missense_variant | 3/6 | 1 | NM_001161425.2 | ENSP00000383922.2 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151664Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 250958Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135664
GnomAD4 exome AF: 0.00000890 AC: 13AN: 1461350Hom.: 0 Cov.: 30 AF XY: 0.00000688 AC XY: 5AN XY: 727004
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151664Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74016
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2024 | The c.47G>A (p.G16E) alteration is located in exon 3 (coding exon 1) of the ZNF610 gene. This alteration results from a G to A substitution at nucleotide position 47, causing the glycine (G) at amino acid position 16 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at